drugset / Trial / NCT01035437
Study for Determination of Feasibility and Toxicity of Pre-Treatment With HPPH (2-1[1-Hexyloxyethyl]-2 Devinyl Pyropheophorbide-a) Photodynamic Therapy Prior to Chemoradiation in Non-Operable Patients With Obstructive Esophageal Cancer
Withdrawn
Roswell Park Cancer Institute
NaSingle-groupOpen-labelTreatment
Summary
This study aim is to find out what effects capecitabine, oxaliplatin and radiation therapy following photodynamic therapy have on esophageal cancer.
Timeline
- Start
- 2009-12
- Primary completion
- 2011-01
- Completion
- 2011-02
Outcome
Outcome not reported
Stopped (Enrollment): “no accrual”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 2-1[1-hexyloxyethyl]-2-devinyl Pyropheophorbide-a) | Unknown | 4 mg/m2 | — |